Title: New drug development
Subtitle: science, business, regulatory, and intellectual property issues cited as hampering drug development efforts : report to congressional requesters
Subjects: Pharmaceutical industry, Drug development, United States, Intellectual property, United States. Food and Drug Administration
Places: United States